Carfilzomib
Carfilzomib (PR-171) is a next generation, irreversible and selective inhibitor of the chymotrypsin-like activity of the proteasome. It displays potent antineoplastic activity.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20 ̊C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
APG02460G 0.1mg
Monoclonal CBS Antibody (monoclonal) (M01), Clone: 30
Sign In for Pricing
View Details MBS9438766-01 0.1 mL (Biotin)
alpha-Synuclein (Ab-125) Conjugated Antibody
Sign In for Pricing
View Details MBS9438766-02 0.1 mL (AF350)
alpha-Synuclein (Ab-125) Conjugated Antibody
Sign In for Pricing
View Details 
MBS9438766-03 0.1 mL (AF405)
alpha-Synuclein (Ab-125) Conjugated Antibody
Sign In for Pricing
View Details 
MBS9438766-04 0.1 mL (AF488)
alpha-Synuclein (Ab-125) Conjugated Antibody
Sign In for Pricing
View Details